DanielJBergMD

Oncology • Iowa City, IA

Associate Professor of Medicine, University Iowa College of Medicine

Join to view full profile

Dr. Berg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berg's full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-353-7800

Fax+1 319-353-8383

Education & Training

University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1986 - 1990
University of Illinois College of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1990 - Present
IA State Medical License 1986 - 2025

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer Start of enrollment: 2006 Nov 01
Terminated
Phase 2
Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer Start of enrollment: 2011 Jul 01
Terminated
Not Applicable
Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG) Start of enrollment: 2011 Jul 01
Terminated
Not Applicable
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme Start of enrollment: 2013 Apr 01
Active, not recruiting
Phase 1
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I Start of enrollment: 2014 Jan 01
Active, not recruiting
Phase 1
Ketogenic Diet Phase 1 for Head & Neck Cancer Start of enrollment: 2014 Jan 01
Terminated
Not Applicable
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer Start of enrollment: 2020 Mar 03
Active, not recruiting
Phase 2
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) Start of enrollment: 2018 Nov 28
Active, not recruiting
Phase 2
Roles: Sub-Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer.
Kellie L Bodeker, Brian J Smith, Daniel J Berg, Chandrikha Chandrasekharan, Saima Sharif
Redox Biology. 2024-11-01
5 citations
Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cance...
Jermaine Coward, Minal A. Barve, Ganessan Kichenadasse, Kathleen N. Moore, Paul R. Harnett
Cancers. 2021-06-26
12 citations
Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy.
Cameron Cushing, Michael S. Petronek, Kellie L. Bodeker, Sandy Vollstedt, Heather Brown
Redox Biology. 2021-01-01

Journal Articles

Pharmacological Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer
Samuel R Schroeder, Matthew S Alexander, Joseph J Cullen, Daniel J Berg, Bryan G Allen, John M Buatti, Clinical Cancer Research

Grant Support

Using Ketogenic Diets To Enhance Radio-Chemo-Therapy RESPONSE: A Phase I TrialNational Cancer Institute2011
Mechanisms Of Nsaid-Induced Inflammatory Bowel DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
Gastric Preneoplasia In H Felis Infected IL10 MiceNational Cancer Institute1998–2002

Professional Memberships

American Society of Clinical Oncology - ASCO
Member